scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH)
CUSIP: 810648105
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 53,364,241
- Total 13F shares
- 12,488,415
- Share change
- +1,366,461
- Total reported value
- $92,413,167
- Price per share
- $7.40
- Number of holders
- 32
- Value change
- +$10,168,930
- Number of buys
- 19
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 810648105?
CUSIP 810648105 identifies SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 810648105:
Top shareholders of SCPH - scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
6.4%
|
3,409,865
|
$19,300,000 | — | 31 Dec 2019 | |
| 5AM Venture Management, LLC |
13F
|
Company |
6.1%
|
3,253,440
|
$18,414,000 | — | 31 Dec 2019 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
6.1%
|
3,247,005
|
$18,378,000 | — | 31 Dec 2019 | |
| Eversept Partners, LP |
13F
|
Company |
0.57%
|
301,636
|
$1,707,260 | — | 31 Dec 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.48%
|
256,133
|
$1,450,000 | — | 31 Dec 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.31%
|
163,677
|
$926,000 | — | 31 Dec 2019 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.23%
|
124,505
|
$704,000 | — | 31 Dec 2019 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
64,200
|
$363,000 | — | 31 Dec 2019 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.1%
|
54,715
|
$310,000 | — | 31 Dec 2019 | |
| Alambic Investment Management, L.P. |
13F
|
Company |
0.1%
|
51,023
|
$289,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
44,873
|
$254,000 | — | 31 Dec 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.07%
|
38,848
|
$220,000 | — | 31 Dec 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.06%
|
31,028
|
$175,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.04%
|
19,896
|
$112,000 | — | 31 Dec 2019 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.03%
|
17,791
|
$101,000 | — | 31 Dec 2019 | |
| Matisse Capital |
13F
|
Company |
0.03%
|
14,685
|
$83,000 | — | 31 Dec 2019 | |
| Old Well Partners, LLC |
13F
|
Company |
0.02%
|
10,852
|
$61,000 | — | 31 Dec 2019 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.02%
|
8,884
|
$51,000 | — | 31 Dec 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
3,217
|
$18,000 | — | 31 Dec 2019 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,781
|
$10,000 | — | 31 Dec 2019 | |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC |
13F
|
Company |
0%
|
1,655
|
$9,000 | — | 31 Dec 2019 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
1,090
|
$6,000 | — | 31 Dec 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
637
|
$4,000 | — | 31 Dec 2019 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
357
|
$2,000 | — | 31 Dec 2019 | |
| HOWE & RUSLING INC |
13F
|
Company |
0%
|
205
|
$1,000 | — | 31 Dec 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
200
|
$1,000 | — | 31 Dec 2019 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
36
|
$204 | — | 31 Dec 2019 |
Institutional Holders of scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) as of Q1 2020
As of 31 Mar 2020,
scPharmaceuticals Inc. - Common Stock, par value $0.0001 per share (SCPH) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,488,415 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, 5AM Venture Management, LLC, Ikarian Capital, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Worth Venture Partners, LLC, Eversept Partners, LP, BOOTHBAY FUND MANAGEMENT, LLC, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
32
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
27
Q1 2020 holders
32
Holder diff
5
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.